{"entity":{"type":"insider","cik":"0001702457","url":"/insider/0001702457","json_url":"/insider/0001702457.json","name":"Newell Joe","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":35,"first":"2018-07-31","last":"2021-11-18","span_basis":"filed_date"},"name_variants":[{"name":"Newell Joe","source":"filing","n_filings":35,"first_seen":"2018-07-31","last_seen":"2021-11-18"}],"transactions":[{"id":4907193,"accession":"0001567619-21-020780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020780","line_url":"/filing/0001567619-21-020780#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3332.0,"shares_display":"3,332","price_per_share":17.1169,"price_display":"17.12","price_state":"stated","total_value":57033.5108,"total_display":"57,033.51","total_whole":"57,034","shares_owned_after":113097.0,"shares_owned_after_display":"113,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":5471660,"accession":"0001567619-21-020653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-020653","line_url":"/filing/0001567619-21-020653#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":17.7149,"price_display":"17.71","price_state":"stated","total_value":124004.3,"total_display":"124,004.30","total_whole":"124,004","shares_owned_after":116429.0,"shares_owned_after_display":"116,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":4906986,"accession":"0001567619-21-017578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-017578","line_url":"/filing/0001567619-21-017578#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":178500.0,"total_display":"178,500.00","total_whole":"178,500","shares_owned_after":119929.0,"shares_owned_after_display":"119,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-24","scope":"insider"},{"id":5417772,"accession":"0001567619-21-017260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-017260","line_url":"/filing/0001567619-21-017260#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3116.0,"shares_display":"3,116","price_per_share":15.6121,"price_display":"15.61","price_state":"stated","total_value":48647.3036,"total_display":"48,647.30","total_whole":"48,647","shares_owned_after":119929.0,"shares_owned_after_display":"119,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4562986,"accession":"0001567619-21-016517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016517","line_url":"/filing/0001567619-21-016517#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":123045.0,"shares_owned_after_display":"123,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-08-31","scope":"insider"},{"id":5377100,"accession":"0001567619-21-016150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016150","line_url":"/filing/0001567619-21-016150#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2426.0,"shares_display":"2,426","price_per_share":12.532,"price_display":"12.53","price_state":"stated","total_value":30402.632,"total_display":"30,402.63","total_whole":"30,403","shares_owned_after":126545.0,"shares_owned_after_display":"126,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":4424806,"accession":"0001209191-21-034430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034430","line_url":"/filing/0001209191-21-034430#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2453.0,"shares_display":"2,453","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":35691.15,"total_display":"35,691.15","total_whole":"35,691","shares_owned_after":128971.0,"shares_owned_after_display":"128,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":4836771,"accession":"0001209191-21-033285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033285","line_url":"/filing/0001209191-21-033285#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":131424.0,"shares_owned_after_display":"131,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-17","scope":"insider"},{"id":4529446,"accession":"0001209191-21-025888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-025888","line_url":"/filing/0001209191-21-025888#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":655.0,"shares_display":"655","price_per_share":14.74,"price_display":"14.74","price_state":"stated","total_value":9654.7,"total_display":"9,654.70","total_whole":"9,655","shares_owned_after":134924.0,"shares_owned_after_display":"134,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":5323052,"accession":"0001209191-21-023583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023583","line_url":"/filing/0001209191-21-023583#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2640.0,"shares_display":"2,640","price_per_share":14.58,"price_display":"14.58","price_state":"stated","total_value":38491.2,"total_display":"38,491.20","total_whole":"38,491","shares_owned_after":135579.0,"shares_owned_after_display":"135,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-30","scope":"insider"},{"id":5395099,"accession":"0001209191-21-020578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-020578","line_url":"/filing/0001209191-21-020578#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":17.41,"price_display":"17.41","price_state":"stated","total_value":121870.0,"total_display":"121,870.00","total_whole":"121,870","shares_owned_after":138219.0,"shares_owned_after_display":"138,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-15","scope":"insider"},{"id":4178049,"accession":"0001209191-21-017773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017773","line_url":"/filing/0001209191-21-017773#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1665.0,"shares_display":"1,665","price_per_share":16.74,"price_display":"16.74","price_state":"stated","total_value":27872.1,"total_display":"27,872.10","total_whole":"27,872","shares_owned_after":141719.0,"shares_owned_after_display":"141,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":4924746,"accession":"0001209191-21-009054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009054","line_url":"/filing/0001209191-21-009054#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3886.0,"shares_display":"3,886","price_per_share":20.39,"price_display":"20.39","price_state":"stated","total_value":79235.54,"total_display":"79,235.54","total_whole":"79,236","shares_owned_after":105669.0,"shares_owned_after_display":"105,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":5243126,"accession":"0001209191-21-003996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-003996","line_url":"/filing/0001209191-21-003996#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":18.84,"price_display":"18.84","price_state":"stated","total_value":131880.0,"total_display":"131,880.00","total_whole":"131,880","shares_owned_after":109555.0,"shares_owned_after_display":"109,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":2799190,"accession":"0001209191-20-064504","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-064504","line_url":"/filing/0001209191-20-064504","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":23.105,"price_display":"23.10","price_state":"stated","total_value":161735.0,"total_display":"161,735.00","total_whole":"161,735","shares_owned_after":116555.0,"shares_owned_after_display":"116,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider","n_lines":2},{"id":2120179,"accession":"0001209191-20-059046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059046","line_url":"/filing/0001209191-20-059046#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1648.0,"shares_display":"1,648","price_per_share":19.774,"price_display":"19.77","price_state":"stated","total_value":32587.552,"total_display":"32,587.55","total_whole":"32,588","shares_owned_after":116555.0,"shares_owned_after_display":"116,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-18","scope":"insider"},{"id":2382921,"accession":"0001209191-20-058464","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-058464","line_url":"/filing/0001209191-20-058464","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.491733333333332,"price_display":"18.49","price_state":"stated","total_value":138688.0,"total_display":"138,688.00","total_whole":"138,688","shares_owned_after":119503.0,"shares_owned_after_display":"119,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-16","scope":"insider","n_lines":2},{"id":2181438,"accession":"0001209191-20-047819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047819","line_url":"/filing/0001209191-20-047819#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1678.0,"shares_display":"1,678","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":20287.02,"total_display":"20,287.02","total_whole":"20,287","shares_owned_after":122203.0,"shares_owned_after_display":"122,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2782533,"accession":"0001209191-20-031007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031007","line_url":"/filing/0001209191-20-031007#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1603.0,"shares_display":"1,603","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":17985.66,"total_display":"17,985.66","total_whole":"17,986","shares_owned_after":123881.0,"shares_owned_after_display":"123,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2075746,"accession":"0001209191-20-023763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-023763","line_url":"/filing/0001209191-20-023763#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":657.0,"shares_display":"657","price_per_share":7.94,"price_display":"7.94","price_state":"stated","total_value":5216.58,"total_display":"5,216.58","total_whole":"5,217","shares_owned_after":125484.0,"shares_owned_after_display":"125,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-07","scope":"insider"},{"id":3165809,"accession":"0001209191-20-021698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021698","line_url":"/filing/0001209191-20-021698#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2740.0,"shares_display":"2,740","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":25125.8,"total_display":"25,125.80","total_whole":"25,126","shares_owned_after":126141.0,"shares_owned_after_display":"126,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-27","filed_date":"2020-03-30","scope":"insider"},{"id":2779392,"accession":"0001209191-20-008126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008126","line_url":"/filing/0001209191-20-008126#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4117.0,"shares_display":"4,117","price_per_share":14.21,"price_display":"14.21","price_state":"stated","total_value":58502.57,"total_display":"58,502.57","total_whole":"58,503","shares_owned_after":53881.0,"shares_owned_after_display":"53,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-10","scope":"insider"},{"id":8619484,"accession":"0001209191-19-051095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-051095","line_url":"/filing/0001209191-19-051095#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":13.51,"price_display":"13.51","price_state":"stated","total_value":47285.0,"total_display":"47,285.00","total_whole":"47,285","shares_owned_after":57998.0,"shares_owned_after_display":"57,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2019-09-30","scope":"insider"},{"id":8026615,"accession":"0001209191-19-027981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-027981","line_url":"/filing/0001209191-19-027981#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":61498.0,"shares_owned_after_display":"61,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-06","filed_date":"2019-05-07","scope":"insider"},{"id":7788825,"accession":"0001209191-19-023491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-023491","line_url":"/filing/0001209191-19-023491#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":39.96,"price_display":"39.96","price_state":"stated","total_value":59940.0,"total_display":"59,940.00","total_whole":"59,940","shares_owned_after":62146.0,"shares_owned_after_display":"62,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":8152639,"accession":"0001209191-19-017038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-017038","line_url":"/filing/0001209191-19-017038","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":36.13466666666667,"price_display":"36.13","price_state":"stated","total_value":54202.0,"total_display":"54,202.00","total_whole":"54,202","shares_owned_after":47346.0,"shares_owned_after_display":"47,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider","n_lines":2},{"id":9270840,"accession":"0001209191-19-021971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-021971","line_url":"/filing/0001209191-19-021971#line-1","is_derivative":false,"issuer_cik":"0001702457","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001702457","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.44,"price_display":"38.44","price_state":"stated","total_value":19220.0,"total_display":"19,220.00","total_whole":"19,220","shares_owned_after":31858.0,"shares_owned_after_display":"31,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-04-01","scope":"insider"},{"id":8615120,"accession":"0001209191-19-006607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-006607","line_url":"/filing/0001209191-19-006607#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":37.8,"price_display":"37.80","price_state":"stated","total_value":37800.0,"total_display":"37,800.00","total_whole":"37,800","shares_owned_after":32358.0,"shares_owned_after_display":"32,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-01","scope":"insider"},{"id":8293847,"accession":"0001209191-19-000518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-000518","line_url":"/filing/0001209191-19-000518#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":31858.0,"shares_owned_after_display":"31,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-02","scope":"insider"},{"id":6370830,"accession":"0001209191-18-060680","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-060680","line_url":"/filing/0001209191-18-060680","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":41.136073333333336,"price_display":"41.14","price_state":"stated","total_value":61704.11,"total_display":"61,704.11","total_whole":"61,704","shares_owned_after":32385.0,"shares_owned_after_display":"32,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-03","scope":"insider","n_lines":3},{"id":6337982,"accession":"0001209191-18-057055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057055","line_url":"/filing/0001209191-18-057055#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":31858.0,"shares_owned_after_display":"31,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-02","scope":"insider"},{"id":6337583,"accession":"0001209191-18-053131","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-053131","line_url":"/filing/0001209191-18-053131","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":41.278666666666666,"price_display":"41.28","price_state":"stated","total_value":61918.0,"total_display":"61,918.00","total_whole":"61,918","shares_owned_after":32258.0,"shares_owned_after_display":"32,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider","n_lines":2},{"id":6267401,"accession":"0001209191-18-049620","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-049620","line_url":"/filing/0001209191-18-049620","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":39.45216,"price_display":"39.45","price_state":"stated","total_value":59178.24,"total_display":"59,178.24","total_whole":"59,178","shares_owned_after":32356.0,"shares_owned_after_display":"32,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-05","scope":"insider","n_lines":2},{"id":6803437,"accession":"0001209191-18-044804","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-044804","line_url":"/filing/0001209191-18-044804","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":37.74,"price_display":"37.74","price_state":"stated","total_value":56610.0,"total_display":"56,610.00","total_whole":"56,610","shares_owned_after":32358.0,"shares_owned_after_display":"32,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-01","scope":"insider","n_lines":4},{"id":6396288,"accession":"0001209191-18-044584","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-044584","line_url":"/filing/0001209191-18-044584","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001702457","owner_name":"Newell Joe","owner_display_name":"Newell Joe","owner_url":"/insider/0001702457","role":"Officer (Chief Tech. Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Tech. Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Tech. Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.7787,"price_display":"35.78","price_state":"stated","total_value":357787.0,"total_display":"357,787.00","total_whole":"357,787","shares_owned_after":33758.0,"shares_owned_after_display":"33,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-07-31","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (Chief Operations Officer)","n_filings":35,"first_seen":"2018-07-31","last_seen":"2021-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001702457","retrieved_at":"2026-08-27T07:09:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}